ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors. - Nie, Wei; Wang, Zhi-Jie; Zhang, Kai; Li, Bing; Cai, Yi-Ran; Wen, Feng-Cai; Zhang, Ding; Bai, Yue-Zong; Zhang, Xue-Yan; Wang, Shu-Yuan; Cheng, Lei; Zhong, Hua; et al. (BMC Medicine, 2022)